Malathi Mathiyazhakan
Impact in
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
-
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
Papers in
-
- HIV/AIDS Research and Interventions 7
-
- Nanoplatforms for cancer theranostics 5
- Photoacoustic and Ultrasonic Imaging 2
- Co-authors
- Chenjie Xu (6 shared papers)Christian Wiraja (3 shared papers)Balasubramanian Ganesh (8 shared papers)Yashpal Singh Malik (1 shared paper)Paul Kumar Upputuri (3 shared papers)Manojit Pramanik (3 shared papers)K. Sivasubramanian (2 shared papers)Claus‐Dieter Ohl (2 shared papers)
In The Last Decade
Malathi Mathiyazhakan
19 papers receiving 338 citations
Peers
Comparison fields: 5 of 89
- Biomaterials 98
- Infectious Diseases 70
- Biomedical Engineering 133
- Pharmaceutical Science 18
- Electronic, Optical and Magnetic Materials 42
Countries citing papers authored by Malathi Mathiyazhakan
This map shows the geographic impact of Malathi Mathiyazhakan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Malathi Mathiyazhakan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Malathi Mathiyazhakan more than expected).
Fields of papers citing papers by Malathi Mathiyazhakan
This network shows the impact of papers produced by Malathi Mathiyazhakan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Malathi Mathiyazhakan. The network helps show where Malathi Mathiyazhakan may publish in the future.
Co-authors
The 25 scholars most cited alongside Malathi Mathiyazhakan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 123 | |
| 2 | 2021 | 90 | |
| 3 | 2014 | 30 | |
| 4 | 2016 | 29 | |
| 5 | 2016 | 21 | |
| 6 | 2016 | 18 | |
| 7 | 2020 | 6 | |
| 8 | 2020 | 3 | |
| 9 | 2020 | 3 | |
| 10 | 2021 | 3 | |
| 11 | 2022 | 3 | |
| 12 | 2021 | 3 | |
| 13 | 2020 | 3 | |
| 14 | 2023 | 2 | |
| 15 | 2016 | 2 | |
| 16 | 2022 | 1 | |
| 17 | 2022 | 1 | |
| 18 | 2020 | 1 | |
| 19 | 2021 | 1 | |
| 20 | 2025 | 0 |
About Malathi Mathiyazhakan
Malathi Mathiyazhakan is a scholar working on Infectious Diseases, Biomedical Engineering, Epidemiology, Electronic, Optical and Magnetic Materials and Biomaterials, having authored 22 papers that have together received 343 indexed citations. Recurring topics across this work include HIV/AIDS Research and Interventions (7 papers), Nanoplatforms for cancer theranostics (5 papers), Gold and Silver Nanoparticles Synthesis and Applications (5 papers), Nanoparticle-Based Drug Delivery (4 papers), HIV, Drug Use, Sexual Risk (4 papers), Sex work and related issues (2 papers), Photoacoustic and Ultrasonic Imaging (2 papers) and Herpesvirus Infections and Treatments (1 paper). The work is most often cited by research in Biomaterials (98 citations), Infectious Diseases (70 citations), Biomedical Engineering (133 citations), Pharmaceutical Science (18 citations) and Electronic, Optical and Magnetic Materials (42 citations). Malathi Mathiyazhakan has collaborated with scholars based in India, Canada and Singapore. Frequent co-authors include Chenjie Xu, Christian Wiraja, Balasubramanian Ganesh, Yashpal Singh Malik, Paul Kumar Upputuri, Manojit Pramanik, K. Sivasubramanian, Claus‐Dieter Ohl, Yu Gao and Caigang Zhu. Their work appears in journals such as Medicine, Science China Materials, Bioengineering & Translational Medicine, International Journal of Microbiology Research and Nano-Micro Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.